Yearly Archives: 2011

Rib-X Pharmaceuticals Raises $20M

Rib-X Pharmaceuticals, Inc., a New Haven, CT-based company that develops broad spectrum antibiotics, has raised $20m in funding.The financing was led by existing...

Avinger Completes $25M Series B Funding Round

Avinger, Inc., a Redwood City, CA-based medical device manufacturer of multi-functional catheters for treating peripheral artery disease (PAD), completed a $25m Series B round...

Dymatize Enterprises Receives Majority Investment from TA Associates

Dymatize Enterprises, Inc., a Dallas, TX-based manufacturer and marketer of branded and private label nutritional and sports supplements, has received a majority investment of...

Sustainability Roundtable Secures $1.2M in Series A Financing

Sustainability Roundtable, Inc., a Cambridge, MA-based research and consulting company focused on best practices for more sustainable facilities, has secured $1.2m in Series A...

Holtzbrinck Ventures Closes Fourth Fund at €177M

Munich, Germany-based Holtzbrinck Ventures has closed its fourth fund, at €177m.HV Holtzbrinck Ventures Fund IV, which will now operate as a fully independent venture...

Beneq Receives €9M Equity Investment

Beneq Oy, a Vantaa, Finland-based a supplier of equipment and coating technology for global markets, has received a €9m equity investment.Investors include Finnish Industry...

Polyplus-transfection Completes €2.5M Funding Round

Polyplus-transfection SA, an Illkirch, France-based company that focuses on  the development of innovative solutions for the delivery of nucleic acids in research and therapeutics,...

Caralon Global Receives First Investment from JumpStart Ventures

Caralon Global, a Cleveland, OH-based company developing and commercializing an ultra-thin, highly efficient insulation product, has received a first investment of undisclosed amount...

VillageVines Completes $3M Series A Financing

VillageVines, a New York-based company that operates a members-only website offering preferred pricing at exclusive restaurants nationwide, completed a $3m Series A financing. Investors...

Interface Biologics Completes $7M Series B Financing

Interface Biologics, Inc., a Toronto, Canada-based commercial stage developer of innovative biomedical-polymer products, completed a $7m Series B financing. The round was led by...

THE DAILY NEWSLETTER - SIGNUP

Latest news